ArticleBMC health services research2026
Latent transition analysis of end-of-life care trajectories among cancer patients in South Korea: a nationwide cohort study.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the prolonged and often fragmented course of care before death among patients with cancer, end-of-life care research has largely relied on cross-sectional snapshots rather than the longitudinal trajectories needed to inform quality improvement. This study aimed to identify distinct end-of-life care trajectories among Korean cancer decedents.
methodsThis retrospective cohort study used a nationwide dataset of all 75,784 individuals who died from cancer in South Korea in 2016 and examined health care utilization trajectories during the final year of life. Health care utilization during the final year of life was summarized using 5 binary indicators: chemotherapy or radiotherapy; high-intensity treatment (intensive care unit admission, mechanical ventilation, cardiopulmonary resuscitation, and vasopressor use); acute-care hospital admission; long-term care hospital (LTCH) admission; and hospice use. These indicators were analyzed using latent transition analysis to identify end-of-life care states, transition probabilities between states, and the most frequent trajectories.
resultsLatent transition analysis identified 5 end-of-life care states: high anticancer therapy use state, high acute-care hospital admission state, high LTCH admission state, minimal inpatient care state, and high hospice use state. Near the end of life, two primary trajectories emerged, collectively accounting for 36.0% of all patients: transitioning from either minimal inpatient care or high anticancer therapy use state into the high acute-care hospital admission state. High state persistence was observed across subsequent intervals; 90.2% of individuals remained in the high LTCH admission state, and 99.1% remained in the high hospice use state. CONCLUSIONS AND RELEVANCE: These findings suggest that end-of-life anticancer therapy, LTCH admission, and hospice use are concurrently or sequentially linked to acute-care hospital utilization. The marked state persistence, coupled with the late-stage initiation and limited duration of hospice care, underscores the critical need for earlier, proactive palliative care integration and timely hospice referrals before high-utilization patterns become entrenched.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.